Literature DB >> 11350865

Drug-disease interactions: reduced beta-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat.

K M Kulmatycki1, K Abouchehade, S Sattari, F Jamali.   

Abstract

Inflammation may influence response to pharmacotherapy. We investigated the effect of inflammation on response to sotalol, a beta-adrenergic receptor and potassium channel antagonist. Racemic sotalol (40 mg kg(-1)) was administered to healthy, acutely (interferonalpha 2a-induced) and chronically (Mycobacterium butyricum-induced adjuvant arthritis) inflamed male Sprague-Dawley rats (n=4 - 6/group). Another group of interferon-treated rats received 3 mg kg(-1) of anti-TNF antibody infliximab. Electrocardiogram (ECG) recorded and plasma sotalol concentration monitored for 6 h. The study was repeated in acutely inflamed rats following administration of stereochemically pure individual sotalol enantiomers [40 mg kg(-1) S (potassium channel blocker) or 20 mg kg(-1) R (beta-adrenergic/potassium channel blocker)]. Chronic arthritis was readily evident. Acute arthritis was associated with elevated segmented neutrophils and increased plasma nitrite and tumour necrosis factor (TNF) concentrations. Sotalol affected ECG in all rats. In both inflamed groups, however, response to sotalol in prolongation of QT interval (potassium channel sensitivity) was reduced. The effect of PR interval (beta-adrenergic activity) was also reduced following administration of the racemate and R-enantiomer. No significant differences in pharmacokinetics were observed between control and inflamed rats. Infliximab reduced nitrite and TNF concentrations and reversed the effect of acute inflammation on both PR and QT intervals. The reduced electrocardiographic responses to sotalol is likely due to the influence of inflammation on the action of the drug on both beta-adrenergic and potassium channel receptors secondary to over-expression of pro-inflammatory cytokines and/or nitric oxide. Our observation may have therapeutic consequences in all conditions where inflammatory mediators are increased.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11350865      PMCID: PMC1572777          DOI: 10.1038/sj.bjp.0704067

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function.

Authors:  P W Verheggen; M P de Maat; V M Cats; F Haverkate; A H Zwinderman; C Kluft; A V Bruschke
Journal:  Eur Heart J       Date:  1999-04       Impact factor: 29.983

2.  Relationship between K+ channel down-regulation and [Ca2+]i in rat ventricular myocytes following myocardial infarction.

Authors:  R Kaprielian; A D Wickenden; Z Kassiri; T G Parker; P P Liu; P H Backx
Journal:  J Physiol       Date:  1999-05-15       Impact factor: 5.182

3.  Elevated C-reactive protein levels in overweight and obese adults.

Authors:  M Visser; L M Bouter; G M McQuillan; M H Wener; T B Harris
Journal:  JAMA       Date:  1999-12-08       Impact factor: 56.272

Review 4.  The role of cytokines in the failing human heart.

Authors:  S Kapadia; Z Dibbs; K Kurrelmeyer; D Kalra; Y Seta; F Wang; B Bozkurt; H Oral; N Sivasubramanian; D L Mann
Journal:  Cardiol Clin       Date:  1998-11       Impact factor: 2.213

5.  Endotoxin and tumor necrosis factor alpha exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardiodepressant profiles.

Authors:  U Müller-Werdan; H Schumann; H Loppnow; R Fuchs; D Darmer; J Stadler; J Holtz; K Werdan
Journal:  J Mol Cell Cardiol       Date:  1998-05       Impact factor: 5.000

6.  Effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents.

Authors:  R E Schneider; H Bishop; M J Kendall; C P Quarterman
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1981-04

7.  A high plasma concentration of TNF-alpha is associated with dementia in centenarians.

Authors:  H Bruunsgaard; K Andersen-Ranberg; B Jeune; A N Pedersen; P Skinhøj; B K Pedersen
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1999-07       Impact factor: 6.053

Review 8.  Sotalol: An important new antiarrhythmic.

Authors:  J L Anderson; E N Prystowsky
Journal:  Am Heart J       Date:  1999-03       Impact factor: 4.749

9.  Tyrosine kinase-dependent modulation by interferon-alpha of the ATP-sensitive K+ current in rabbit ventricular myocytes.

Authors:  M Nishio; Y Habuchi; H Tanaka; J Morikawa; T Okanoue; K Kashima
Journal:  FEBS Lett       Date:  1999-02-19       Impact factor: 4.124

Review 10.  Alpha-interferon-induced arthritis: clinical presentation treatment, and prevention.

Authors:  G Nesher; R Ruchlemer
Journal:  Semin Arthritis Rheum       Date:  1998-06       Impact factor: 5.532

View more
  6 in total

1.  Drug-disease interaction: Crohn's disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activity.

Authors:  Forough Sanaee; John D Clements; Alistair W G Waugh; Richard N Fedorak; Richard Lewanczuk; Fakhreddin Jamali
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

2.  Cardiovascular effect of inflammation and nonsteroidal anti-inflammatory drugs on renin-angiotensin system in experimental arthritis.

Authors:  Waheed Asghar; Ali Aghazadeh-Habashi; Fakhreddin Jamali
Journal:  Inflammopharmacology       Date:  2017-04-07       Impact factor: 4.473

3.  Despite increased plasma concentration, inflammation reduces potency of calcium channel antagonists due to lower binding to the rat heart.

Authors:  Saeed Sattari; William F Dryden; Lise A Eliot; Fakhreddin Jamali
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

4.  Effects of angiotensin II blockade on inflammation-induced alterations of pharmacokinetics and pharmacodynamics of calcium channel blockers.

Authors:  S Hanafy; N J Dagenais; W F Dryden; F Jamali
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

5.  Local anesthetic failure associated with inflammation: verification of the acidosis mechanism and the hypothetic participation of inflammatory peroxynitrite.

Authors:  Takahiro Ueno; Hironori Tsuchiya; Maki Mizogami; Ko Takakura
Journal:  J Inflamm Res       Date:  2008-11-13

6.  QT Interval and QT Dispersion in Patients Undergoing Hemodialysis: Revisiting the Old Theory.

Authors:  Mohamed A Alabd; Walid El-Hammady; Ahmed Shawky; Wail Nammas; Mohamed El-Tayeb
Journal:  Nephron Extra       Date:  2011-07-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.